Metabolix labeled a risky, speculative stock

September 23, 2013 |

In Seeking Alpha, the guide warns against investing in Metabolix for all but the most risk-tolerant investors. Claiming that the company is struggling to develop new sources of revenue, with a shrinking cash reserve and no financing for a new commercial-scale facility after the termination of its joint venture with DSM. The article also cites the turbulent price of the stock over the last year, pointing out repeated 50% swings up and down.

More on the story.

Print Friendly, PDF & Email

Tags: ,

Category: Producer News

Thank you for visting the Digest.